Sign up for a FREE subscription to Myeloma Today,
the official newsletter of the IMF!
What's New at the IMF:
Dr. Andrew von Eschenbach to Deliver Keynote Address at the IMF's Washington D.C. Patient & Family Seminar
The IMF is pleased to announce that Dr. Andrew von Eschenbach, the newly-appointed director of the National Cancer Institute, will be the keynote speaker at the Seminar Welcome Dinner on Friday, June 7th!
Click here to learn more about the Washington D.C. Patient & Family Seminar or to register for this empowering meeting.
Mark Your Calendars: Join the IMF for the 3rd Annual OVAC Advocacy Day
The myeloma community needs your help! Join us in Washington D.C. on June 3rd and 4th as we lobby Congress to increase funding for diversified research and prevention programs at the National Institutes of Health (NIH), the National Cancer Institute (NCI) and cancer programs at Centers for Disease Control and Prevention (CDC). OVAC has been credited with maintaining recent funding increases for federal cancer research funding. Click here to learn more about what this event means to members of the myeloma community.
Every Myeloma Advocate Needs an IMF Ribbon of Hope!
Whether or not you're able to join us in Washington, you can still be an advocate for the myeloma community and show your support by proudly wearing an official IMF Ribbon of Hope pin. Our Multiple Myeloma Ribbon of Hope lets people know you care and calls attention to the need for action to find a cure. Making it truly distinct are the two Ms in the center of the ribbon, MM for multiple myeloma. You can obtain an official IMF Ribbon of Hope pin by making a tax-deductible donation (minimum donation of $5, please) in any amount that you feel is appropriate. You can order a Ribbon of Hope online, or by mailing a check to the International Myeloma Foundation (please specify that you'd like a Ribbon of Hope). You may also order via phone, by calling (800) 452-CURE.
Items of Interest:
Learn All You Need to Know About Clinical Trials!
The IMF is pleased to announce that members can now download a wide array of educational brochures detailing the clinical trials process. These materials have been posted on the IMF's website with the permission of the National Cancer Institute. Should you experience difficulties downloading any of the publications, you can call 1-800-4-CANCER to request that a copy be mailed to you.
Industry News & Company Press Releases:
EntreMed's Next Generation Angiogenesis Inhibitors Highlighted At AACR Annual Meeting.
Celgene Corporation Presents Preclinical Data on Two Classes Of Orally Available Cytokine Inhibitors.
NeoRx Updates Status of Targeted Therapeutic Product Development Programs.
Living With Myeloma: Survivor Stories ($13.95)
Living With Myeloma: Survivor Stories is a book written by members of the Los Angeles area myeloma support group. This book tells the stories of 22 MM patients and their journeys through diagnosis and treatment for their disease. Their stories are highly varied, as are their symptoms and treatments, but all are filled with hope and commitment to the best treatment possible. You can order a copy online, or by calling (800) 452-CURE.
New York Times - Personal Health
What's a Cancer Patient to Do When Even the Experts Can't Agree?
By JANE E. BRODY
New York Times
Test Proves Fruitless, Fueling New Debate on Cancer Screening
By GINA KOLATA
Help Us Help Others...
As a non-profit organization, the IMF is completely dependent on the support of our members. Please consider showing your support by making a tax-deductible donation today. Donations in honor of a friend or family member make great gifts and are a wonderful way to celebrate a special occasion. You can donate online or by calling the IMF at (800) 452-CURE. We sincerely thank you for your support.
View Back Issues Online...
New to the IMF Myeloma Minute? See what you've been missing by viewing previous issues online!
If you no longer wish to receive the Myeloma Minute, please visit the log-in page, enter your email address, password, first and last name and click the "unsubscribe" button at the bottom of the page.